Navigation Links
EarPeace Introduces Elegant, High-fidelity Hearing Protection Solution
Date:12/15/2009

Virtually invisible hearing protection that allows users to control the volume without compromising sound-quality or comfort.

Washington, DC (PRWEB) Dec. 15, 2009 -- EarPeace (www.earpeace.com) is redefining hearing protection with high-fidelity, virtually invisible ear plugs that are available in three different skin-tone colors. "As a big fan of live-music and having already lost a measure of my hearing, I was looking for a way to continue my active lifestyle in a loud world,” says founder Jay Clark. “There was nothing on the market, so I created EarPeace as a discrete hearing protection solution that provides high-quality sound, comfort, and comes in an elegant case that is the perfect complement to a night out.”

Anyone who loves live music, clubbing or dancing has come home after a night out with ringing, buzzing ears - an indicator of permanent damage. EarPeace was developed to improve the nightlife experience without sacrificing sound quality, comfort, or style. The most common protection currently on the market are bulky, foam ear plugs that protect, but significantly reduce sound quality and are very obvious when worn. EarPeace is a superior new option for protecting your hearing.

Tested at the foremost audio testing facility in the country, silicone EarPeace ear plugs, with their patented pull-tab design, are virtually invisible from the outside and let in a small amount of unobstructed sound. They protect hearing while delivering a superior experience. Reusable silicone EarPeace comes in a sleek, aluminum tube, available in red or silver, which attaches easily to a key chain or slips neatly into a small purse or pants pocket.

EarPeace will revolutionize the hearing protection market, for both concert goers and industry professionals. "
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Delta Dental of Illinois Introduces Smile Smart For Your Health
2. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
3. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
4. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
5. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
6. Triveris Introduces Personal Health Record with Built-in Health Advisor
7. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
8. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
9. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
10. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
11. ThermoTx Introduces New Mobile Stimulation (TENS) Product Line for On the Go Therapy and Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
EarPeace Introduces Elegant, High-fidelity Hearing Protection Solution
(Date:8/1/2014)... research at Washington University School of Medicine in St. ... in males and frequently are more harmful than similar ... malignant brain tumors, are diagnosed twice as often in ... do not survive as long. , The researchers found ... cancer risk, is significantly less active in male brain ...
(Date:8/1/2014)... -- The U.S. Food and Drug Administration announced on ... help fight type 2 diabetes. Jardiance (empagliflozin) ... regimens to control blood sugar levels in the overall ... Office of Drug Evaluation II in the FDA,s Center ... statement. The FDA also recommended that Jardiance be ...
(Date:8/1/2014)... 2014 The evolving healthcare landscape ... pharmacies. At ThoughtSpot 2014, AmerisourceBergen and Good Neighbor ... and resources to enhance patient care and profitability. ... critical issues to give independent pharmacists the tools ... , ThoughtSpot show attendance experienced a nearly 70% ...
(Date:8/1/2014)... Growing prevalence of chronic ailments, ... are boosting healthcare market growth, although a reduction ... increasing generic consumption is a major challenge. , ... 2013, having grown at a Compound Annual Growth ... of the Health Transformation Program (Saglikta Donus, um ...
(Date:8/1/2014)... FRIDAY, Aug. 1, 2014 (HealthDay News) -- Patients with ... pulmonary disease (COPD) have a new weapon to battle ... Thursday. The agency approved a new treatment, ... the third leading killer of Americans. COPD, which is ... as chronic bronchitis and emphysema. Patients with ...
Breaking Medicine News(10 mins):Health News:Study reveals one reason brain tumors are more common in men 2Health News:FDA Approves New Type 2 Diabetes Drug 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 3Health News:ThoughtSpot 2014 Inspires as General Session Concludes 4Health News:ThoughtSpot 2014 Inspires as General Session Concludes 5Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 4Health News:FDA Approves New Treatment for People With COPD 2
... Urges Senate to Quickly Pass this Important Lifesaving ... Connor, American Lung Association President and CEO:Today in ... in favor with a strong bipartisan majority for ... the Family Smoking Prevention and Tobacco Control Act ...
... Finding could steer caregivers away from situations that would add ... levels of a stress hormone may be responsible for the ... children with a certain type of autism. , ... not experience the normal twofold increase of cortisol upon waking ...
... CITY, Mo., April 2 Argus Health Systems, Inc., ... received an award from the Flaspohler Research Group as ... of Interest" in the 2008 PBM Survey of ... ranked by survey participants based on specific attributes, including ...
... know where and when patients and staff interact, giving ... influenza transmission patternsATLANTA, April 2 Radianse, Inc. today ... University Hospital Midtown, Atlanta, is using the Radianse ... know early and reliably where, when and with whom ...
... 2009 Can we always see what is in front of ... and Cognitive Neuroscience at The City College of New York (CCNY), ... Journal of Neuroscience " by Professor Ro and colleagues from the ... brainwave activity is in a trough. , "We may have our ...
... (omega-3s), namely EPA and DHA found in seafood and ... benefits, but evidence of other benefits continues to stack ... menopausal women and healthier weight loss in obese dieters ... these topics are summarized in the March 2009 ...
Cached Medicine News:Health News:U.S. House of Representatives Again Votes with a Strong Bipartisan Majority in Favor of Granting the U.S. FDA Regulatory Control Over Tobacco Products 2Health News:Asperger Syndrome Tied to Low Cortisol Levels 2Health News:Argus Honored by Flaspohler Research Group as Highest-Rated PBM for 'No Conflicts of Interest' 2Health News:Radianse Announces Real-Time Tracking of Emory ED Staff and Patients to Trace and Contain Infectious Disease Spread 2Health News:Neuroscientists demonstrate link between brainwave acticity and visual perception 2Health News:Omega-3s May Benefit Newborns, Menopausal Women and Obese Individuals 2
(Date:8/1/2014)... 2014 Research and Markets ... Medical Biosensors Market 2014-2018" report to their ... Medical biosensors are used to analyze ... These biosensors monitor health status, disease betterment, and ... They are cost-effective and user-friendly devices. Also, they ...
(Date:8/1/2014)... , Aug. 1, 2014 MGC Diagnostics ... company, announced today that it has completed its ... of cardiorespiratory diagnostic products based in Sorinnes, ... served the European cardiorespiratory diagnostics market since 1977. ... of approximately €4.7 million ($6.3 million) and incurred ...
(Date:8/1/2014)... 1, 2014  Neuland Laboratories Ltd., (NSE:NEULANDLAB; BSE-Scrip ... ingredients (APIs), complex intermediates and custom ... countries, today announced financial results for the first ... 30, 2014. "Neuland,s results in the ... to accommodate certain customer needs, and we do ...
Breaking Medicine Technology:Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche 2MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 2MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 3MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 4Neuland Labs Reports First Quarter Fiscal Year 2015 Financial Results 2Neuland Labs Reports First Quarter Fiscal Year 2015 Financial Results 3
... presented at Israel Society of Nephrology Conference ... months from single treatment - Data continue to ... expensive injections MISGAV, Israel and LONDON, March 27 ... latest, encouraging results of the Company,s ongoing EPODURE Biopump ...
... of Clinical Lipidology publishes largest study comparing cancer ... using FDA database -BOSTON, March 25 A ... ezetimibe mono and ezetimibe/simvastatin combination treatments, compared to ... The study, conducted by Tufts Medical Center ...
Cached Medicine Technology:Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients 2Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients 3Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients 4Ezetimibe and Ezetimibe/Simvastatin Combo Pose No Increased Cancer Risk, Study Shows 2
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
For use with catalog #0454....
Medicine Products: